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Abstract. The vast majority of studies has demonstrated that periodontal infection promotes 
significant systemic inflammatory status. The specific effects of these systemic alterations in 
response to periodontal inflammation have been comprehensively described and appear to be 
highly stereotyped, and it is well known the pathophysiological mechanism related to immune 
functioning linking periodontitis and pathologies such as diabetes or cardiovascular diseases, 
adverse pregnancy outcomes, and rheumatoid arthritis. More recently, it has been proposed that 
this association could be extended to consider periodontal infection as trigger to complications in 
maintenance haemodialysis (HD) patients through the establishment of inflammatory status in 
association to impaired nutritional status, emphasizing the role of periodontal infection in 
increase of C-reactive protein serum marker, a  notably  predictor of the cardiovascular risk. The 
aim of this narrative review was to summarize the currently literature evidence that has 
developed around the potential impact of periodontal inflammatory status on serum nutritional 
and inflammatory biomarkers concentration monitoring the severity of systemic conditions in HD 
patients, in which cardiovascular events and malnutrition are the most common causes of 
mortality and morbidity. 
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Methods: an electronic PubMed, Google Scholar and Cochrane database search complemented by a 
manual search of the bibliographies cited in all identified articles was performed between 2012 
and 2019. The inclusion criteria were: all types of articles, articles published in PubMed, , Google 
Scholar and Cochrane  and related only to humans. The exclusion criteria were: articles for which 
full text was not available, were not in English, or were grey literature. Keywords set: 
hemodialisys serum markers and periodontitis have been combined through the use of Mesh 
search. The terms then inserted in Pubmed were “serum markers”, “hemodialisys”, “periodontal 
disease” OR “periodontal infection” OR “periodontal inflammation”.  
Results: thirteen articles were identified. Studies currently available on the impact of periodontitis 
on the serum markers level in HD patients are analogous. Results confirmed the impact of 
subclinical inflammation related to periodontitis on C-reactive protein and albumin serum levels,  
supporting the emerging hypothesis of relationship between periodontal infection and HD status. 
Conclusions: although many studies have suggested that the inflammatory cytokines release may 
play a key role in several clinical alterations related to HD maintenance, further studies are 
needed to investigate the long-term consequences of chronic inflammation caused by 
periodontitis. There is a paucity of data concerning to the impact of periodontal disease on 
maintenance hemodialysis patients and about mechanisms involved.  Clinical trial and 
observational studies summarized here suggest but do not prove that persistent low level 
inflammation periodontitis-related are causing harm to hemodialysis maintenance. 
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Introduction 
 
   How exposure to periodontal infection promotes general inflammation is an area of great 
interest and currently, investigation on the mechanistic link between periodontal inflammation 
and general diseases  is the topic of intense research (1-2-3-4). This effort is encouraged by an 
amply literature about the link between inflammatory status periodontitis-induced and the risk of 
contribution for progression of severe pathologies such as diabetes or atherogenesis, adverse 
pregnancy outcomes, and rheumatoid arthritis. (5-6). It has been recognized  the critical role of 
periodontitis  in indirectly modulating immune response (7). The low-grade systemic 
inflammation supported and maintained by the worsened periodontal inflammation provides to 
the intensification of inflammatory signals from the periphery because of the perpetuate 
activating of the inflammatory cascade. According to the consensus report by the Joint European 
Federation of Periodontology (EFP) and American Academy of Periodontology (AAP) workshop, 
statistically significant additional risk was found for atherosclerotic cardiovascular disease in 
patients with periodontitis, independent of other co-morbidities (7-8). Specifically, it is now 
accepted that periodontitis is an independent risk factor that threatens the general immune system 
balance (9). Local periodontal stimuli and processes may transmit the inflammatory response to 
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other organs  through two potentially mechanisms: (a) Direct migration and colonization of 
periodontal pathogens bacteria to distant organs eliciting an inflammatory reaction distant from 
the focus of infection (10); (b) establishment of systemic inflammation derived by metastatic 
periodontal inflammation or resulted  by activated soluble inflammatory pathways by 
blood-borne periodontal bacteria (10-11).  
   There is strong evidence that chronic inflammation plays a significant role in determining the 
level of nutritional and inflammatory parameters and, specifically, of serum albumin, C-reactive 
protein, and other biomarkers in haemodialysis patients (12). High CRP level is a sign of 
inflammatory state and it is commonly associated to chronic disease, and is a relevant predicting 
factor of cardiovascular events and poor outcome (13). Hypoalbuminemia is associated with 
inflammatory burden in the body, liver disease, renal disease and malnutrition (14-15). Several 
evidences suggest that periodontal inflammation is associated to decrease of serum albumin levels 
but, concerning patients undergoing haemodialysis,  there is paucity of knowledge regarding the 
potential relationship with nutritional status and  involved mechanisms. In this brief narrative 
review the periodontal inflammation is presented as a potential amplifier factor of the serum 
biomarkers, such as CRP, albumin and other nutritional biomarkers, level alteration.  
   Recently, based on the existing evidence, it has been proposed that this conceptualization could 
be extended to onset of clinical complications in HD patients because chronic inflammation has 
been shown to exert biological activity on pathogenesis of haemodialysis-related alterations 
(16-17-18). Indeed, environmental factors that might play a critical role in the aetiology of 
atherosclerosis and malnutrition in these individuals include exposure to general inflammation 
(19). Periodontitis is related with local and systemic rise in inflammatory cytokines and acute 
phase proteins and there is a few evidence that periodontitis, considering all available evidence on 
the contribute of chronic inflammation as promoting factor for systemic inflammation, might 
compromise clinical outcomes in patients undergoing hemodialysis (20). Hemodialysis patients 
are more prone to develop inflammation. It is multifactorial and may derive from few sites and 
chronic stimuli. Many authors underlined that onset of the inflammatory response in end-stage 
renal disease (ESRD) is associated with an increase of serum acute-phase proteins, involving CRP 
and elevated activation and release in blood of pro-inflammatory cytokines such as IL-6 and 
TNF-α that may induce muscle breakdown and hypoalbuminemia and may be implicated in 
atherogenesis process (21). 
   Increased levels of inflammatory markers such as CRP and IL-6 are known predictors of 
cardiovascular outcomes in the general population as well as in the HD population (22), where 
they are also linked to malnutrition and the role of these serum markers on endothelial 
dysfunction has been largely examined. Several dialysis-related traditional risk factors, such as 
bioincompatibility (23) between blood and dialyzer, the presence of endotoxins in dialysis fluid 
and access-related infections are responsible for high serum CRP levels (24), and contribute to 
onset of clinical complications in HD patients, but current research suggest that a variety of 
non-traditional risk factors may play a significant role in alterations in their immune and 
host-defence system. Impaired nutritional status and cardiovascular complications in HD patients 
are two of the most common leading causes of mortality and morbidity in this population. 
Attention however has now diverged with greater understanding of immunogenic pathways, 
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regarding the role of inflammation in HD, which has been questioned and studied. Clinical 
repercussion of cytokines circulation has been emphasized by Henderson et al. which formulated 
the interleukin hypothesis (25). 
   Periodontal disease can be a source of inflammatory response and, as demonstrated by 
meta-analytical studies, inflammation plays a key mediating role in positive association between 
periodontal disease and cardiovascular disease. Available data of atheromasique plaque specimen 
study (26) with in vivo studies demonstrate the many facets of periodontal inflammation 
contribute to the aetiopathogenesis of endothelial dysfunction. The role of periodontal infection 
on nutritional status in HD patients has been questioned by means of clinical investigations 
evaluating the basic inflammation and nutritional status markers fluctuation in HD patients 
affected by periodontal disease (27). More recently, numerous studies highlighted also the 
responsibility of microinflammation on contributing to malnutrition by several ways, including 
decrease in albumin synthesis and protein catabolism leading to loss of lean body mass (28-29). 
Specifically, on the basis of evidence obtained from experimental and clinical studies, it appears 
that chronic inflammation may be implicated in protein energy malnutrition and contribute to 
progressive atherosclerosis in HD patients (30). Several papers highlighted the role of systemic 
inflammatory response as responsible of increased protein catabolism and decreased protein 
intake with consequent malnutrition status (31).  Negative nitrogen balance, weight loss and 
anorexia are more prevalent in HD patients due to inflammation. Malnutrition might originate 
from inflammatory status (32) and these conditions could interrelate establishing a composite 
clinical status in which inflammation and malnutrition each other reciprocally (33). An interesting 
contribute to this line of reasoning is evidence demonstrating the association between 
malnutrition, increased levels of CRP and prevalence of cardiovascular events in patients 
undergoing hemodilaysis, suggesting the presence of the syndrome defined 
Malnutrition-Inflammation-Atherosclerosis (MIA), responsible of premature death in this 
population (33-34). Periodontitis it has been shown a potential key role in systemic inflammation 
in HD patients, because of the positive correlation between C-reactive protein levels (CRP) and 
immunoglobulin G of periodontal pathogens (35). This narrative review was aimed to summarize 
the currently literature evidence that has developed around the potential impact of periodontal 
inflammatory status on serum nutritional and inflammatory biomarkers concentration monitoring 
the severity of systemic conditions in HD patients, in which cardiovascular events and 
malnutrition are the most common causes of mortality and morbidity. 
 
 
 
Methods 
 
   An electronic PubMed, Google Scholar and Cochrane database search was assessed between 
2002 and 2019. From the articles identified in the first search, additional references were identified 
by a manual search among the cited references. The inclusion criteria were: all types of articles, 
articles published in PubMed,  Google Scholar and Cochrane  and related only to humans. The 
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exclusion criteria were: articles for which full text was not available, were not in English, or were 
grey literature. Keywords set: hemodialisys serum markers and periodontitis have been combined 
through the use of Mesh search. The terms then inserted in Pubmed were “serum markers”, 
“hemodialisys”, “periodontal disease” OR “periodontal infection” OR “periodontal 
inflammation”.  
 
 
 
 
 
Results 
 
   Thirteen articles were identified. Studies currently available on the impact of periodontitis on 
the serum markers level in HD patients are analogous.  
 
C-reactive protein (CRP), Albumin and other serum markers  level in  HD patients  and Periodontal 
Disease 
 
C-reactive protein is an acute-phase protein and established non-specific indicator of 
inflammation. CRP is currently considered a key biomarker of systemic inflammation (36).  It 
reflects the production and release of pro-inflammatory cytokines, such as Interleukine-1 (IL-1), 
IL-6 and TNF-α (37-38). Its blood concentration increases from less than about 1µg/ml to as high as 
600/1000 1µg/ml during the height of an acute phase response. CRP is synthesized primarily in the 
liver by hepatocytes in response to the pro-inflammatory cytokines. An elevated level of CRP is a 
well-established marker for cardiovascular events risk on general population and HD patients.  
Since CRP is produced in response to inflammatory stimuli, several studies have shown that their 
levels are increased in subjects with periodontal disease when compared with healthy control 
population. Meta-analyses and systematic reviews of the relationship of CRP to periodontitis have 
shown consistently higher CRP levels in patients than in controls and that non-surgical 
periodontal treatment had a positive effect on reduction of the serum levels of C-reactive protein 
(39-40). Periodontal infection is implicated in increase of C-reactive protein concentration, 
suggesting a potential role of periodontitis as independent factor in addition to the documented 
risks for cardiovascular events. On the basis of this conceptualization many authors have focused 
their research about the ability of PD to became source of systemic inflammation favoring 
progression of complications in patients undergoing HD.     
   Specifically, Yazdi et al (41) conducted a clinical study to analyze the impact of non-surgical 
periodontal treatment on serum CRP levels on patients with periodontitis on maintenance 
hemodialysis. Results of this study showed a significant reduction in serum concentration of CRP 
after periodontal treatment ( p < 0.001). Margaret et al. (42) at New York University undertaken a 
study to investigate whether periodontal inflammatory status could be associated to increase of 
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C-reactive protein (>10 mg/L) concentration in HD patients. The serum profiles for levels of 
immunoglobulin g (IgG) antibody of 86 subjects were drawn. Results showed that higher levels of 
IgG antibody significantly associated to periodontal pathogens P(=0.02) were associated to  
enhanced inflammatory response expressed in higher CRP levels (P=0.013). Kadiroglu et al. (2006) 
performed a prospective clinical study on 41 HD patients demonstrating a significant positive 
correlation between CRP levels and Plaque Index (PI) (r=0.319; P=0.045) and Gingival Index (GI) 
(r=0.317; P=0.046) (43). Further, an observational study of 253 HD patients conducted in Taiwan 
suggested that poor periodontal status could be a sign of malnutrition as well as chronic systemic 
inflammation. The results of this study showed a negative correlation between periodontitis and 
serum albumin level (r=-0.291; P<0.01) and blood urea nitrogen level (r=-0.161; P<0.01), but it was 
positively correlated with high-sensitivity C-reactive protein (r=0.212; P<0.01) (44). Of interest, 
Naghsh N et al (45) also provided data indicating that periodontal inflammation may affect 
general conditions in HD patients. In their cross-sectional study the authors evaluated whether 
the periodontal disease could modulate the alteration of some nutritional status serum markers 
level on patients undergoing hemodialysis. The authors observed that the mean serum levels of 
albumin (P=0.02) and ferritin (P=0.043) were significantly lower in subjects with periodontitis 
compared with subjects with gingivitis. Further, they detected a significant correlation between 
CAL and serum level of Calcium (P=0.046), Creatinine (P=0.02), Cystatin C (P=0.013), and 
Phosphorus (P=0.037) in patients with periodontitis. Siribamrungwong M et al. reported a positive 
correlation between hs-CRP and periodontal disease severity. They also found the negative 
association between CRP and hemoglobin and albumin. Further, they observed decreased CRP 
levels after periodontal treatment (46). Rahamati et al. conducted a study on 86 patients 
undergoing hemodialysis to evaluate the impact of periodontal inflammation on serum 
concentration of CRP, assessing levels of immunoglobulin G (IgG) antibody to six periodontal 
species. They showed that elevated levels of  CRP were associated with resulting high Log serum 
IgG antibody levels to Porphyromonas gingivalis (P  0.013) (47). Vilela et al also examined the 
effect of periodontal treatment in chronic kidney disease patients versus control patients group. 
The study design was an interventional, controlled, nonrandomized clinical trial in which the 
participants, all of whom had a diagnosis of periodontal disease was analyzed for the following 
blood parameters: C-reactive protein, interleukin-6, and prohepcidin. Each patient was subjected 
to non-surgical periodontal treatment. The efficacy of PT was indicated by the significant 
decreases in the levels of  ultrasensitive C-reactive protein, interleukin-6 and serum prohepcidin 
levels in both groups (48).  The cross-sectional study conducted by Kshirsagar was aimed to 
examine the association between sera levels of albumin and CRP and periodontitis. 154 
individuals undergoing haemodialisys were recruited. A multiple linear regression analysis of all 
biochemical parameters was applied to determine the association. Results showed that 
periodontitis was significantly independently associated with alteration of sera biomarkers (49). 
Depending on the approach followed, a number of different biochemical  parameters have been 
employed as indices of nutritional status and inflammation in HD patients  such as 
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serum albumin, phosphorus, creatinine, transferrin, ferritin, iron, alkaline phosphatase, calcium, 
potassium and haemoglobin (50).    
   Several studies have demonstrated that serum albumin concentrations are associated with 
general health. The amount of albumin serum concentration is depending on many factors, such 
as the rate of hepatic synthesis and secretion, exchanges between intra- and extravascular 
compartments, lymphatic uptake, alterations of the volume of distribution and protein 
degradation rate, and body lasses (51). Inflammation and malnutrition both reduce albumin 
concentration by decreasing its rate of synthesis. Albumin is a trace negative serum protein 
produced by the liver, that decreases significantly in concentration in inflammatory conditions. It 
is a marker of malnutrition that is widely employed in several studies. Remarkably, it became 
recognized that serum albumin concentration is determined by inflammation through its 
association with C-reactive protein (CRP) (52).  
   The involvement of inflammation in plasma serum level decrease is strengthened by 
demonstrating the reduced synthesis of proteins and their increased catabolic rate (53). A series of 
available data indicate that periodontal inflammation exposure is positively associated to 
hypoalbuminemia. Periodontal disease, because of its chronicity could cause low-grade systemic 
inflammation and promote serum albumin levels decrease in these patients. Periodontal infection 
cause a marked activation of the immune system with the injection of the pro-inflammatory 
molecules, including cytokines such as tumor necrosis factor-α (TNF-α) and free radicals such as 
nitric oxide (54). In addition to significant inverse correlation between periodontal disease and 
serum levels of albumin, inflammation periodontitis-related it seems to interact with malnutrition 
status in HD patients (55).  Kaur et al. (55) examining the effects of gingivitis and periodontitis on 
serum albumin concentration. This study was conducted on 60 patients, divided into two groups 
to distinguish healthy subjects and patients with periodontitis. Results showed a statistically 
association between serum albumin levels and Gingival Index (P=0.002) and Plaque Index 
(P<0.001) in patients with periodontitis compared to healthy subjects. Further, were emphasized a 
statistically highly significant differences between the serum albumin levels in two groups (P < 
0.001). More recently, the association between periodontal status and serum calcium levels (sCa), 
phosphorus (sP), alkaline phosphatase (sAP), parathormone (PTH) have been also studied by 
Cholewa et al. Results of this study emphasized the previous highlighted negative correlation 
between serum albumin level and periodontal inflammation, and not significant correlation 
between phosphorus level and between calcium level  and periodontal state was observed (56). 
Similarly, Rodrigues et al. (57) conducted a cross-sectional study, enrolling a total of 96 patients. 
They measured albumin, phosphorus, creatinine, transferrin, ferritin, iron, alkaline phosphatase, 
calcium, potassium and haemoglobin serum markers and executed periodontal clinical 
parameters examination, to evaluate if periodontitis could influence eventual changes of 
biomarkers. The prevalence rate of periodontitis registered was more of 50%. The authors 
revealed that there was significant linear relationship between periodontitis and albumin 
(p=0.021) and phosphorus (p=0.024) serum levels when compared to the group without 
periodontitis. The other biomarkers levels correlated positively with periodontitis, but showed no 
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significant correlation, were transferrin and haemoglobin. Despite these findings, in a randomized 
controlled trial of periodontal treatment effect on serum albumin levels and high-sensitivity IL-6 
in patients receiving HD not benefits in these biomarkers concentration were observed in both 
groups (58). Patients were randomly assigned to the periodontal therapy group vs no treatment 
group. In contrast, results of Randomized Controlled Trial conducted by Wehmeyer et collegues 
(59) not showed evident impact of periodontal status on serum markers of inflammation in HD 
patients.   
   Moreover, periodontal treatment was not associated with a significant improvement in IL-6 
pro-inflammatory mediator or in the concentration of serum albumin level, even after adjustment 
for potential confounding variables. Many investigations have used the serum albumin 
concentration and CRP as a markers of inflammatory activity and malnutrition status. A review of 
available data indicates that periodontal inflammation exposure is positively associated to 
hypoalbuminemia. Results confirmed the impact of subclinical inflammation related to 
periodontitis on C-reactive protein and albumin serum levels, supporting the emerging 
hypothesis of relationship between periodontal infection and HD inflammatory status (59-60). 
 
 
Discussion 
 
   Periodontitis continues to mark very high indipendent risk for progression of several systemic 
disease and several clinical trials have revealed interesting findings about the association between 
periodontitis and  inflammatory and nutritional serum biomarkers concentration in patients 
undergoing hemodialysis. The impact of periodontal inflammation on low-grade albuminuria has 
been  amply investigated, especially in patients with kidney disease (61-62-63).  A majority of 
clinical trials  highlighted the positive effect of periodontal therapy on CRP and albumin levels as 
outcome measure after periodontal therapy, suggesting the potential role of microinflammation 
periodontitis-derivative on these biomarkers level.  We have not randomized controlled trials on 
which to confirm this link, but clinical trials investigating the effectiveness of periodontal therapy 
on CRP and albumin serum levels indicate improvement of systemic conditions in HD patients 
(34-35). Periodontitis should be considering as a common and modifiable risk factor for systemic 
complications in patients undergoing hemodialysis. The mechanism linking periodontitis and 
systemic condition  of HD individuals are complex and multifactorial (1-2-8-64). As discussed, it 
involves the critical impact on C-reactive protein and albumin dysregulation among others serum 
biomarkers concentration indicating nutritional and inflammatory status (65-66-67). The 
implications for research is that further understanding of the pathophysiological mechanisms 
supporting the impact of periodontal inflammation on HD general status is required so as to 
improve treatments (68-69-70). It would be interesting to see not only studies looking at 
underlying biological mechanisms but also clinical ones. Given the bidimensionality of these 
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conditions (71-72-73), it would be useful to clarify whether non-surgical periodontal treatment for 
HD can potentially contribute to improvement of HD systemic condition. 
 
 
Conclusions 
 
   Periodontal disease is correlated with systemic inflammation (1-74-60-61). Literature data 
evolving to suggest the involvement of periodontal inflammation as contributing factor on 
decreased serum albumin level and CRP in haemodialysis patients (75-76-77). This potential 
mechanistic link might provide multiple interesting targets for new and multidisciplinary 
therapeutic interventions. Few reports suggested that control of local periodontal infection was 
associated with a decrease in levels of serum inflammatory markers in HD patients (78-79). In 
recent years, it has become evident that periodontal infection plays a pivotal role in various 
pathological systemic condition. Here we presented a short narrative review of the existing 
literature on the effect of periodontal inflammation on patients in hemodialisys maintenance 
(80-81-82). Depending on the approach followed, a number of different biochemical parameters 
have been employed as indices of nutritional status and inflammation in HD patients such as 
serum albumin, phosphorus, creatinine, transferrin, ferritin, iron, alkaline phosphatase, calcium, 
potassium and haemoglobin. Many investigations have used the serum albumin concentration 
and CRP as a markers of inflammatory activity and malnutrition status in HD population. 
Although the effects of PD on HD are mixed, we find that albumin levels are the most linked 
markers to PD , which supports the emerging hypothesis of correlation between periodontal 
inflammation on HD status. More longitudinal studies are also needed to evaluate the association 
of serum biomarkers levels with periodontitis in hemodialysis patients. 
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